EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #67
EMCDDA. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2018. 549 kB. #THF-F
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #Tetrahydrofuranfentanyl
Wilde, M; Pichini, S; Pacifici, R; Tagliabracci, A; Busardò, FP; Auwärter, V; Solimini, R. Metabolic pathways and potencies of new fentanyl analogs Front. Pharmacol., 5 Apr 2019, 10 (238). 1.5 MB. https://doi.org/10.3389/fphar.2019.00238 #Tetrahydrofuranylfentanyl
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review Neuropharmacology, 1 May 2018, 134, 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #Tetrahydrofuranfentanyl
Anon. INCB: Fentanyl-related substances with no known legitimate use 24 Jun 2018, n/a. 189 kB. #84
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #Tetrahydrofuranylfentanyl